Dupont Capital Management Corp Karyopharm Therapeutics Inc. Transaction History

Dupont Capital Management Corp

  • $1.06 Billion
  • Q4 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 26, 2023
BUY
$2.48 - $5.93 $56,933 - $136,135
22,957 New
22,957 $0
Q2 2022

Jul 26, 2022
BUY
$4.15 - $8.37 $56,971 - $114,903
13,728 Added 60.4%
36,455 $164,000
Q1 2022

Apr 27, 2022
SELL
$5.91 - $14.38 $175,379 - $426,726
-29,675 Reduced 56.63%
22,727 $167,000
Q4 2021

Jan 31, 2022
SELL
$5.21 - $8.61 $108,852 - $179,888
-20,893 Reduced 28.51%
52,402 $337,000
Q3 2021

Nov 03, 2021
BUY
$4.45 - $10.63 $326,162 - $779,125
73,295 New
73,295 $427,000

Others Institutions Holding KPTI

# of Institutions
98
Shares Held
57.6M
Call Options Held
258K
Put Options Held
81.2K
View Full List

About Karyopharm Therapeutics Inc.

KPTI Quotes by TradingView
  • Ticker KPTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 79,806,600
  • Market Cap $53.5M
  • Description
  • Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...
More about KPTI
Track This Portfolio

Track Dupont Capital Management Corp Portfolio

Follow Dupont Capital Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Dupont Capital Management Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email